Beijing, China

Jianquan Zheng

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.8

ph-index = 1


Company Filing History:


Years Active: 2011-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jianquan Zheng

Introduction

Jianquan Zheng is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of medicine and the chemical industry. With a total of 2 patents, his work focuses on developing innovative solutions for various health-related issues.

Latest Patents

Zheng's latest patents include the invention of 4,4-diphenylpiperidine compounds or pharmaceutically acceptable salts thereof. This invention relates to a pharmaceutical composition that has shown significant activity in blocking N-type calcium channels. The compound has demonstrated good pharmacokinetic properties and potential as a new medicament for the prevention or treatment of pain, stroke, cerebral ischemia, and other conditions. Another notable patent involves polyethylene glycol modifications of thymosin alpha-1, which are used in medicine to prevent and treat diseases related to immune deficiency and hypoimmunity, including hepatitis B, hepatitis C, and AIDS.

Career Highlights

Zheng has worked with esteemed institutions such as the Academy of Military Medical Sciences and the Institute of Pharmacology and Toxicology, both part of the Academy of Military Medical Sciences, P.L.A., China. His research and innovations have contributed to advancements in medical treatments and pharmaceutical applications.

Collaborations

Zheng has collaborated with notable colleagues, including Cheng Zhang and Haoshan Wang, to further his research and development efforts in the medical field.

Conclusion

Jianquan Zheng's innovative work and patents reflect his dedication to improving healthcare through scientific advancements. His contributions continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…